Apexbio B7582

ATP?S tetralithium salt
B7582-10 10 mg
EUR 304.8

Apexbio Reagents Laboratories manufactures the apexbio b7582 reagents distributed by Genprice. The Apexbio B7582 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Apexbio products are available in stock. Specificity: Apexbio Category: B7582

Human Samples information

GF 109203X
A8342-5 5 mg
EUR 142.8
Description: GF 109203X is a potent and selective inhibitor of protein kinase C [1].

GF 109203X
A8342-5.1 10 mM (in 1mL DMSO)
EUR 199.2
Description: GF 109203X is a potent and selective inhibitor of protein kinase C [1].

GF 109203X
A8342-S Evaluation Sample
EUR 97.2
Description: GF 109203X is a potent and selective inhibitor of protein kinase C [1].

Go 6983
A8343-10 10 mg
EUR 247.2
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1].

Go 6983
A8343-5 5 mg
EUR 177.6
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1].

Go 6983
A8343-5.1 10 mM (in 1mL DMSO)
EUR 199.2
Description: Go 6983 is a selective inhibitor of PKC?, PKC?, PKC?, PKC? and PKC? with IC50 value of 7 nM, 7 nM, 6 nM, 10 nM, and 20 mM, respectively [1].

K-252c
A8344-1 1 mg
EUR 204
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively.

K-252c
A8344-25 25 mg
EUR 1452
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively.

K-252c
A8344-5 5 mg
EUR 616.8
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively.

K-252c
A8344-5.1 10 mM (in 1mL DMSO)
EUR 518.4
Description: K-252c is a cell-permeable, reversible, and ATP-competitive inhibitor of protein kinase C (PKC) and protein kinase A (PKA) with IC50 value of 2.45 ?M and 25.7 ?M, respectively.

PF-562271 HCl
A8345-10 10 mg
EUR 324
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.

PF-562271 HCl
A8345-5 5 mg
EUR 226.8
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.

PF-562271 HCl
A8345-5.1 10 mM (in 1mL DMSO)
EUR 393.6
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.

PF-562271 HCl
A8345-50 50 mg
EUR 714
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.

PF-562271 HCl
A8345-S Evaluation Sample
EUR 97.2
Description: PF-562271 is a potent, ATP-competitive and reversible inhibitor of both focal adhesion kinase (FAK), a non-receptor tyrosine kinase involved in a variety of cellular events, and proline-rich tyrosine kinase 2 (Pyk2), an FAK homolog containing 48% amino acid identity.

BYL-719
A8346-100 100 mg
EUR 1039.2
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers.

BYL-719
A8346-20 20 mg
EUR 338.4
Description: BYL719 is a selective PI3K? inhibitor with IC50 of 5 nM. It has minimal effect on PI3K?, ? and ?[1]. Dysregulation of the PI3K signaling pathway is involved in multiple cancers.